Live Breaking News & Updates on Jason Lettmann|Page 3

Stay updated with breaking news from Jason lettmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Significant Decline in Short Interest

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) was the recipient of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 2,910,000 shares, a decline of 16.4% from the February 29th total of 3,480,000 shares. Approximately 10.7% of the shares of the stock […] ....

New Zealand General , New Zealand , United States , Shelly Pinto , Stifel Nicolaus , Jason Lettmann , American International Group Inc , Oncology Holdings Inc , Alx Oncology Holdings Inc , Oncology Company Profile , Group Plc , Wellington Management Group , Vanguard Group Inc , Jefferies Financial Group , Pricet Rowe Associates Inc , Get Free Report , Financial Group , Management Group , International Group , General Group Plc , Holdings Inc , Alx Oncology , Nasdaq Alxo ,

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $18.42 Average PT from Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price […] ....

United States , Stifel Nicolaus , Shelly Pinto , Jason Lettmann , Forefront Analytics , Sg Americas Securities , Alx Oncology Holdings Inc , Hsbc Holdings , Jp Morgan Private Wealth Advisors , Oncology Holdings Inc , Jefferies Financial Group , Barclays Plc , Securities Exchange Commission , Get Free Report , Financial Group , Exchange Commission , Private Wealth Advisors , Get Free , Holdings Inc ,

ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, ....

San Francisco , United States , Malini Chatterjee , Karen Sharma Macdougall , Jason Lettmann , Peter Garcia , Oncology Holdings Inc , Development Pillars , Holdings Inc , Chief Executive Officer , Healthcare Conference , Rational Design , Dual Development , Peter Garcia Chief Financial Officer , Life Science Group , Media Contact ,